Growth hormone is not the anti-aging bullet for healthy adults

January 15, 2007

PHILADELPHIA, Jan. 16, 2007 -- A review of published data on use of human growth hormone (GH) by healthy elderly people found that the synthetic hormone was associated with small changes in body composition but not in body weight or other clinically important outcomes.

Further, people who took GH had increased rates of unhealthy side effects such as soft tissue swelling, joint pain, carpal tunnel syndrome, and, in men, abnormal breast development. They were also somewhat more likely to develop diabetes.

The review, "The Safety and Efficacy of Growth Hormone in the Healthy Elderly," was published in the Jan. 16, 2007, issue of Annals of Internal Medicine and is available on the Web at www.annals.org on that day.

"Growth hormone has been widely promoted as an anti-aging therapy," said Hau Liu, MD, a research fellow in endocrinology and health policy at Stanford University and an author of the review.

"But the scant clinical experience of GH in the healthy elderly suggests that although GH may minimally alter body composition, it does not improve other clinically relevant outcomes such as bone density, cholesterol levels, stamina, and longevity in this population.

"And it's associated with high rates of adverse events.

"So, on the basis of available evidence, we cannot recommend growth hormone use for anti-aging in the healthy elderly."

Human growth hormone, a protein produced by the pituitary gland, helps regulate growth during childhood and metabolism in adults.

In the United States, the FDA has approved the drug, now produced synthetically, to treat children with short stature and some other growth problems caused by childhood diseases.

The FDA has approved GH to treat adults with growth hormone deficiency syndrome. Its use for anti-aging falls into a grey area. The FDA prohibits drug companies from marketing GH for off-label uses such as anti-aging.

Yet thousands of adults use GH as an anti-aging drug. One estimate is that 20,000 to 30,000 adults used it for anti-aging purposes in the United States in 2004.

The Web is replete with ads for all kinds of products said to contain GH, from pills, sprays, injections, secretagogues, homeopathic formations, and GH releasers and enhancers. GH, often in conjunction with vitamins, testosterone and other hormones, is said to increase muscle strength and mass, decrease body fat, improve mood and motivation, increase exercise capacity, increase bone density and (wink, wink) make wives and girlfriends happy.

Despite these enticing claims, careful review of existing evidence does not support the prescription of GH for anti-aging purposes.

Growth hormone is among the most expensive of all hormones used for replacement therapy. One physician estimated that a year's supply for an adult with GH-deficiency caused by pituitary disease would cost between $7,500 and $10,000 per year. Estimates of the cost of GH for anti-aging purposes range from $1,000 per month to $2,000 per month.

"Everyone is looking for the fountain of youth," Liu said. "We wanted to see if there is any validity behind some of the claims made about growth hormone's anti-aging properties.

"Our biggest surprise was the general lack of research that had been done in this area. When we reviewed the scientific evidence, we found that there were really only about 500 patients involved in rigorous controlled trials. And only a few more than 200 actually received growth hormone.

"Think about all the scientific claims made on anti-aging Web sites based on this small population of patients. The FDA typically doesn't approve a drug until it's been tested in thousands of patients.

"In our review, we found that growth hormone increased lean body mass or muscle mass by slightly more than two kilograms (that's a little over four pounds) and decreased fat mass by about two kilograms. But it had no other beneficial effects that we could see.

"If you went to a gym pretty regularly, you might get that change without breaking into too much of a sweat, and you wouldn't spend $1,000 to $2,000 a month on something that appears to have modest or minimal benefit and the probability of bad side effects," said Liu.
-end-
NOTE: Offices of Annals of Internal Medicine and the American College of Physicians are closed on Monday, Jan. 15, 2007, reopening on Jan. 16. Please call for embargoed article and interviews on Jan. 11 or Jan. 12 or Tuesday, Jan. 16. Also, this article is the subject of a video news release. Coordinates follow.

Annals of Internal Medicine (www.annals.org) is one of the most widely cited peer-reviewed medical journals in the world. The journal has been published for 80 years and accepts only 7 percent of the original research studies submitted for publication.

Annals of Internal Medicine is published by the American College of Physicians (www.acponline.org), the largest medical specialty organization and the second-largest physician group in the United States.

ACP members include 120,000 internal medicine physicians (internists), related subspecialists, and medical students. Internists specialize in the prevention, detection, and treatment of illness in adults.

NOTES TO EDITORS:

1. To reach Dr. Liu, call: Louis Bergeron, Stanford Office of Communications, 650-723-0272.

2. This article is the subject of a video news release from the American College of Physicians.
Satellite Feed Times:
Monday January 15th, 2007
Times: 10:00 AM - 10:15 AM Eastern
9:00 AM - 9:15 AM Central
8:00 AM - 8:15 AM Mountain
7:00 AM - 7:15 AM Pacific
C-Band Satellite: INTELSAT A-6
Transponder: 24
Downlink: 4180 (H) Audio: 6.2 & 6.8

Monday January 15th, 2007
Times: 2:00 PM - 2:15 PM Eastern
1:00 PM - 1:15 PM Central
12:00 PM - 12:15 PM Mountain
11:00 AM - 11:15 AM Pacific
C-Band Satellite: INTELSAT A-6
Transponder: 24
Downlink: 4180 (H) Audio: 6.2 & 6.8

Date: Tuesday, January 16th, 2007
Times: 1:30 PM - 1:45 PM Eastern
12:30 PM - 12:45 PM Central
11:30 AM - 11:45 AM Mountain
10:30 AM - 10:45 AM Pacific
C-Band Satellite: INTELSAT A-6
Transponder: 5
Downlink: 3800 (V) Audio: 6.2 & 6.8

The Pathfire information will be as follows.

This story is available on the Pathfire DMG
On the News/Video News Feeds Section at D S Simon Productions
Tab: Medical Story Slug: HGH not fountain of youth.
Story Number: ACP23

American College of Physicians

Related Growth Hormone Articles from Brightsurf:

Growth hormone plays key role in early puberty, breast cancer risk
Girls who enter puberty early in life--as measured by early breast development and age of first menstrual period--have a longer window of susceptibility to breast cancer.

Human growth hormone treatment after ACL injury may prevent loss of muscle strength
A new study finds the use of HGH treatment in patients that have undergone ACL reconstructive surgery may prevent the loss of muscle strength and weakness.

Liver surgery success boosted by growth hormone
Growth hormone has been identified as playing a key role in reducing inflammation and increasing survival rates following liver surgery.

Growth hormone acts to prevent weight loss
A Brazilian study shows that, like leptin, growth hormone contributes directly to energy conservation when the body loses weight.

Cost savings from growth hormone insurance strategies not passed on to patients
Increasingly aggressive insurance strategies have lowered the total costs and insurance costs of growth hormone drugs, but those savings are not being passed on to patients, according to new research to be presented Sunday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

Patients bear increased financial burden for growth hormone treatment despite FDA approval
Despite an FDA approval of growth hormone treatment for children with idiopathic short stature (ISS), the mean cost burden to patients and their families has increased over time.

Growth hormone may provide new hope for stroke survivors
Less fatigue and better recovery of cognitive abilities such as learning and memory.

FASEB Science Research Conference: Growth Hormone/Prolactin
This SRC will bring together international scientists from academia and industry for lively discussions on the latest developments in the growth hormone (GH)/prolactin (PRL) family of hormones and their clinical applications.

Low thyroid hormone before birth alters growth and development of fetal pancreas
Levels of thyroid hormone in babies influences insulin-secreting cells of the pancreas, according to a new study published in The Journal of Physiology.

When should doctors treat short children and teens with growth hormone?
When is it appropriate to treat short children with growth hormone?

Read More: Growth Hormone News and Growth Hormone Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.